SCHEMBL23212732

SCHEMBL23212732

Nc1cnn(C2CCCc3ccccc32)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 1/20 0.45
▸ CTSD P07339 1/20 0.44
▸ IDO1 P14902 2/20 0.43
▸ PDE7A Q13946 1/20 0.42
▸ PDE7B Q9NP56 1/20 0.42
▸ HSD11B1 P28845 1/20 0.40
▸ HTR6 P50406 1/20 0.39
▸ F2 P00734 1/20 0.39
▸ F12 P00748 1/20 0.39
▸ OPRM1 P35372 3/20 0.39
▸ OPRK1 P41145 2/20 0.39
▸ OPRL1 P41146 1/20 0.39
▸ KCNH2 Q12809 1/20 0.38
▸ ADRA2A P08913 2/20 0.37
▸ ADRA1A P35348 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ADRA1D P25100 1/20 0.37
▸ ADRA1B P35368 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29751647 1.00 CHRNA7 (0.45) CHRNA7CTSDIDO1PDE7APDE7B
Hydrochloric Acid SCHEMBL23212660 0.99 IDO1 (0.44) CHRNA7CTSDIDO1PDE7APDE7B
Hydrochloric Acid SCHEMBL29751753 0.99 IDO1 (0.44) CHRNA7CTSDIDO1PDE7APDE7B
SCHEMBL22619811 0.91 HTR6 (0.41) CHRNA7CTSDIDO1HSD11B1HTR6
SCHEMBL30839410 0.91 HTR6 (0.41) CHRNA7CTSDIDO1HSD11B1HTR6
Hydrochloric Acid SCHEMBL22619807 0.90 IDO1 (0.41) CHRNA7CTSDIDO1HTR6
Hydrochloric Acid SCHEMBL22619864 0.90 IDO1 (0.41) CHRNA7CTSDIDO1HTR6
Hydrochloric Acid SCHEMBL31039804 0.90 IDO1 (0.41) CHRNA7CTSDIDO1HTR6
SCHEMBL23212694 0.77 MEN1 (0.46) CHRNA7PDE7APDE7BHSD11B1F2
SCHEMBL29751635 0.77 MEN1 (0.46) CHRNA7PDE7APDE7BHSD11B1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041727-B1 ATF6 MODULATORS AND USES THEREOF ALTOS LABS INC (US) 2026-05-20 — — EP disclosed
US-20220389001-A1 ATF6 MODULATORS AND USES THEREOF ALTOS LABS, INC. 2022-12-08 — — US disclosed
US-20220389001-A1 ATF6 MODULATORS AND USES THEREOF ALTOS LABS, INC. 2022-12-08 — — US disclosed
CN-115135645-A ATF6 modulators and uses thereof 普拉西斯生物技术有限责任公司 2022-09-30 — — CN disclosed
EP-4041727-A1 ATF6 MODULATORS AND USES THEREOF Praxis Biotech LLC (US) 2022-08-17 — — EP disclosed
WO-2021069701-A1 ATF6 MODULATORS AND USES THEREOF BLACK BELT TX LTD (GB) 2021-04-15 — — WO disclosed
WO-2021069701-A1 ATF6 MODULATORS AND USES THEREOF BLACK BELT TX LTD (GB) 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220389001-A1 ATF6 MODULATORS AND USES THEREOF ATF4, XBP1, ATF1 CHRNA7 4340/4885CTSD 2435/4885IDO1 4770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback